Environmental Tobacco Smoke Exposure Among Children by Urinary Biomarkers and Parent Report.


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
Historique:
received: 02 07 2020
revised: 22 12 2020
accepted: 02 01 2021
pubmed: 13 1 2021
medline: 29 7 2021
entrez: 12 1 2021
Statut: ppublish

Résumé

The goal of this study was to describe environmental tobacco smoke (ETS) exposure using urinary biomarkers and its correlation with parent report, among children presenting to emergency room. This is a case control study among children aged 3 to 12 years at a tertiary pediatric emergency department in Israel. Children with respiratory (case) or gastrointestinal (control) symptoms were recruited and their accompanying parent completed a short survey. Urine samples were obtained and analyzed for nicotine, cotinine trans-3'-hydroxycotine. Clinical data were extracted from medical records. We compared tobacco exposure using urinary biomarkers, parent report, and Pearson's product-moment correlation, including 95% confidence intervals, between cases and controls. Forty-nine cases with respiratory symptoms and 96 controls with gastrointestinal symptoms were enrolled in the study. Parent-reported ETS exposure in the previous month was higher in the cases compared to control (71.4% vs 57.3%), although the difference was not statistically significant. The mean values of detectable biomarkers did not differ by between cases and controls. However, there was a correlation between urinary biomarkers and reported ETS exposure (0.278-0.460 for various biomarkers) only among cases. The majority of children in this study had detectable nicotine urinary biomarkers, regardless of their symptoms. However, correlation between parental report and urinary biomarkers was only found among children with symptoms potentially related to ETS. These findings imply that parents of children without respiratory symptoms may underestimate exposure. Efforts to educate parents and caregivers on the risks associated with exposure to ETS should be intensified, regardless of illness.

Identifiants

pubmed: 33434701
pii: S1876-2859(21)00003-6
doi: 10.1016/j.acap.2021.01.004
pii:
doi:

Substances chimiques

Biomarkers 0
Tobacco Smoke Pollution 0
Cotinine K5161X06LL

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-669

Informations de copyright

Copyright © 2021 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Maya Leventer-Roberts (M)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai (M Leventer-Roberts, SS Andra, M Arora, and H Levine), New York, NY; Department of Pediatrics, Icahn School of Medicine at Mount Sinai (M Leventer-Roberts), New York, NY. Electronic address: maya.roberts@gmail.com.

Ayala Grinshpun (A)

Pediatric Emergency Unit, Shamir Medical Center (Assaf Harofeh) (A Grinshpun and E Kozer), Tzrifin, Israel; Shamir Academic Nursing School, Shamir Medical Center (A Grinshpun), Tzrifin, Israel.

Elkana Kohn (E)

Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh) (E Kohn and M Berkovitch), Tzrifin, Israel.

Syam S Andra (SS)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai (M Leventer-Roberts, SS Andra, M Arora, and H Levine), New York, NY.

Manish Arora (M)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai (M Leventer-Roberts, SS Andra, M Arora, and H Levine), New York, NY.

Matitiahu Berkovitch (M)

Clinical Pharmacology and Toxicology Unit, Shamir Medical Center (Assaf Harofeh) (E Kohn and M Berkovitch), Tzrifin, Israel; Sackler School of Medicine, Tel Aviv University (M Berkovitch and E Kozer), Tel Aviv, Israel.

Eran Kozer (E)

Pediatric Emergency Unit, Shamir Medical Center (Assaf Harofeh) (A Grinshpun and E Kozer), Tzrifin, Israel; Sackler School of Medicine, Tel Aviv University (M Berkovitch and E Kozer), Tel Aviv, Israel.

Philip Landrigan (P)

Program for Global Public Health and the Common Good, Schiller Institute for Integrated Science and Society, Boston College (P Landrigan), Chestnut Hill, Mass.

Hagai Levine (H)

Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai (M Leventer-Roberts, SS Andra, M Arora, and H Levine), New York, NY; Braun School of Public Health, Hebrew University-Hadassah (H Levine), Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH